Ribosomal Proteins and Colorectal Cancer
Journal:
Current Genomics
Volume:
8
Page:
43-49
Author(s):
Lai Mao-De and Xu Jing
Editorial [Hot Topic: Targeting the IGF-I Receptor Signaling Pathway:Implications for Human Cancer Therapy (Executive Editors: A. Ciampolillo and F. Giorgino) ]
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
661-662
Author(s):
Anna Ciampolillo and Francesco Giorgino
The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
671-686
Author(s):
Antonino Belfiore
Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
687-703
Author(s):
Isabel Varela-Nieto, Markus Hartl, Itziar Gorospe and Yolanda Leon
Crosstalk between IGF Signaling and Steroid Hormone Receptors in Breast Cancer
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
705-717
Author(s):
Diego Sisci and Eva Surmacz
The IGF Axis in Prostate Cancer
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
719-727
Author(s):
S. Monti, L. Proietti-Pannunzi, A. Sciarra, F. Lolli, P. Falasca, M. Poggi, F. S. Celi and V. Toscano
The IGF-I Axis in Thyroid Carcinoma
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
729-735
Author(s):
A. Ciampolillo, C. De Tullio, E. Perlino and E. Maiorano
Anti-Tumor Activity of Non-Nucleosidic Reverse Transcriptase Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
737-747
Author(s):
Matteo Landriscina, Corrado Spadafora, Mauro Cignarelli and Carlo Barone
A Role for Milk Proteins and their Peptides in Cancer Prevention
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
813-828
Author(s):
P. W. Parodi
Cytotoxic and Allergenic Potential of Bioactive Proteins and Peptides
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
897-920
Author(s):
Rainer Hartmann, Jean-Michel Wal, Herve Bernard and Anne-Kathrin Pentzien